Efficient neutron capture therapy of glioblastoma with pteroyl-closo-dodecaborate-conjugated 4-(p-iodophenyl)butyric acid (PBC-IP)

Improved Boron Neutron Capture Therapy Using Integrin αvβ3-Targeted Long-Retention-Type Boron Carrier in a F98 Rat Glioma Model

(2023) Kohei Tsujino et al.   Biology-Basel

Designation Products: Boron Neutron Capture Therapy for Head and Neck Carcinoma

(2021) Hitoshi Kanno et al.   ONCOLOGIST

Exploiting the folate receptor α in oncology

(2020) Mariana Scaranti et al.   Nature Reviews Clinical Oncology

Water-Soluble closo-Docecaborate-Containing Pteroyl Derivatives Targeting Folate Receptor-Positive Tumors for Boron Neutron Capture Therapy

(2020) Fumiko Nakagawa et al.   Cells

Cyclic RGD-Functionalized closo-Dodecaborate Albumin Conjugates as Integrin Targeting Boron Carriers for Neutron Capture Therapy

(2020) Kazuki Kawai et al.   MOLECULAR PHARMACEUTICS

Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): An open-label phase II trial

(2020) Katsumi Hirose et al.   RADIOTHERAPY AND ONCOLOGY

Synthesis and biological evaluation of closo -dodecaborate ibuprofen conjugate (DIC) as a new boron agent for neutron capture therapy

(2018) Satomu Ishii et al.   JOURNAL OF ORGANOMETALLIC CHEMISTRY

closo-Dodecaborate-conjugated human serum albumins: preparation and in vivo selective boron delivery to tumor

(2018) Hiroyuki Nakamura et al.   PURE AND APPLIED CHEMISTRY

Folate receptor-targeted novel boron compound for boron neutron capture therapy on F98 glioma-bearing rats

(2018) Takuya Kanemitsu et al.   RADIATION AND ENVIRONMENTAL BIOPHYSICS

Albumin-Binding Evans Blue Derivatives for Diagnostic Imaging and Production of Long-Acting Therapeutics

(2016) Orit Jacobson et al.   BIOCONJUGATE CHEMISTRY

Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy

(2016) Zhibo Liu et al.   CHEMICAL SOCIETY REVIEWS

Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy

(2016) Shunsuke Kikuchi et al.   JOURNAL OF CONTROLLED RELEASE

Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer

(2013) M. Suzuki et al.   JOURNAL OF RADIATION RESEARCH

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

(2012) Rolf F Barth et al.   Radiation Oncology

Human serum albumin: From bench to bedside

(2011) Gabriella Fanali et al.   MOLECULAR ASPECTS OF MEDICINE

Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors

(2009) Kathleen M. McNeeley et al.   BIOMATERIALS

Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor β

(2009) Taku Nagai et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A Portable Albumin Binder from a DNA-Encoded Chemical Library

(2008) Christoph E. Dumelin et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE